Updike eCom GmbH – Trademark Portfolio

Entity Type: 27

Updike eCom GmbH holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 21 (Housewares) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PEST24.

Dietrich-Bonhoeffer-Str. 25

73630 Remshalden

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PEST24
PEST24
Registered 2021

Trademark Classifications

Updike eCom GmbH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Updike eCom GmbH have?

Updike eCom GmbH has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Updike eCom GmbH file in?

Updike eCom GmbH files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 21 (Housewares), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What are Updike eCom GmbH's most well-known trademarks?

Updike eCom GmbH's registered trademark portfolio includes well-known marks such as PEST24. These are among 1 currently registered trademark in the portfolio.

What is Updike eCom GmbH's trademark registration success rate?

Updike eCom GmbH has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.